Bite-Sized Biochemistry #32 – Neurotransmission/Electron Transport – Video

(01/14/11) Lecture by Kevin Ahern of Oregon State University discussing Biochemistry Basics in BB 451. See the full course at oregonstate.edu This course can be taken for credit (wherever you live) via OSU's ecampus. For details, see ecampus.oregonstate.edu Download Metabolic Melodies at http://www.davincipress.com Related courses include BB 350 - oregonstate.edu BB 450 - oregonstate.edu BB 100 - oregonstate.edu 1

Go here to see the original:
Bite-Sized Biochemistry #32 - Neurotransmission/Electron Transport - Video

Regular Teeth Cleanings Could Cut Heart Attack Risk: Study

(HealthDay News) -- People who visit the dentist regularly to have their teeth cleaned may lower their risk for heart attack or stroke, new research suggests.

The finding is to be presented Sunday at the American Heart Association's annual meeting, in Orlando, Fla.

In following more than 100,000 people with no history of heart problems or stroke for an average of seven years, researchers from Taiwan found those who had their teeth scraped and cleaned by a dentist or dental hygienist at least twice a year for two years had a 24 percent lower risk for heart attack and a 13 percent lower risk for stroke compared to those who never went to the dentist or only went once in two years.

"Protection from heart disease and stroke was more pronounced in participants who got tooth scaling at least once a year," said Dr. Emily (Zu-Yin) Chen, a cardiology fellow at the Veterans General Hospital in Taipei in a news release from the American Heart Association. Read more...

Ayurtox for Body Detoxification

Source:
http://anti-aging-for-today.blogspot.com/feeds/posts/default?alt=rss

Pathology Visions Conference Draws Digital Pathology Professionals from Around the World

Congratulations to the award winners and travel award recipients. Great turnout for this meeting complete with CME and attendees from 17 countries.  

An unprecedented number of digital pathology professionals attended the 7th annual Pathology Visions Conference earlier this month. The Digital Pathology Association (DPA) gathering in San Diego featured more than 50 presenters and 42 educational sessions. Participants from 30 states, 17 countries, and 174 organizations left with a greater understanding of the cutting-edge applications of digital pathology. For those unable to attend the conference and who want to earn CME credits, two of the conference presentations, the keynote address and regulatory panel discussion, are now available online.

(PRWEB) November 22, 2011

An unprecedented number of digital pathology professionals attended the 7th annual Pathology Visions Conference earlier this month. The Digital Pathology Association (DPA) gathering in San Diego featured more than 50 presenters and 42 educational sessions.

“We had the highest number of attendees in the history of our conference, and we are very proud of the role the Pathology Visions Conference plays in the education of those in the digital pathology profession,” said Dirk Soenksen, President of the Digital Pathology Association and Chair of the Pathology Visions Program Committee. “At this year’s conference, we had participants from 30 states, 17 countries, and 174 organizations who left with a greater understanding of the cutting-edge applications of digital pathology. We’re already planning for next year’s conference which will be held Oct. 28 - 31, 2012 in Baltimore, MD. ”

For the first time, the Indiana State Medical Association offered physician attendees of the Pathology Visions Conference the opportunity to earn up to 13 continuing medical education (CME) credits. For those who were not able to attend and still want to earn CME credits, two of the conference presentations, the keynote address and regulatory panel discussion, are now available online.

The Regulatory Panel discussion entitled, “Navigating Digital Pathology’s Path to Patients” was led by Dr. Stephen Hewitt, NCI and a member of the 2009 FDA Hematology and Pathology Devices Advisory Panel on Digital Pathology. Others on the panel included: Tremel Faison, MS, RAC, SCT (ASCP) representing the FDA Office of In Vitro Diagnostic Device Evaluation and Safety; Walter Henricks, M.D., Cleveland Clinic, representing the CAP Laboratory Accreditation Program and the CAP Quality Center Work Group on whole slide imaging systems; and Debra Sydnor representing the CMS Division of Laboratory Services (overseeing CLIA).

Dr. Mahul B. Amin’s keynote presentation was entitled, “Personalized Medicine: Empowering Light Microscopy and the Pathologist.” Dr. Amin is the Chairman and Professor of the Department of Pathology and Laboratory Medicine at Cedars-Sinai Medical Center. His presentation reviewed the role of the pathologist in contemporary healthcare and discussed the contributions, strengths, and limitations of traditional microscopy.

Recordings of the keynote session or the Regulatory Panel discussion can be purchased by clicking here.

Also new to the conference this year was the Pathology Visions Poster Presentation Contest. The competition gave attendees the opportunity to be rewarded for their digital pathology knowledge. Winners included:

Best Poster by a Resident – Bryan Dangott, University of Utah Medical Center; Automated Image Analysis, Scoring and Automation

Honorable Mention Resident – Brad Chaser, MD, Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK; Using Whole Slide Digital Images to Assess and Monitor Resident Progress in Surgical Pathology

Best Research Poster – Christopher Tully, Aperio, Genie Classifier Development for Histology Pattern Recognition

Honorable Mention for Research – Kate Lillard, Aperio; Evaluation of an Automated Histology Pattern Recognition Tool for Selection and Analysis of Viable Tumor in Xenograft Sections Stained with CD-31

Best Education Poster – Dr. Brad Chaser, University of Oklahoma Health Sciences Center; Using Whole Slide Digital Images to Assess and Monitor Resident Progress in Surgical Pathology

Honorable Mention Education – Dr. Steven Schmechel, University of Minnesota; Development of Multigene Expression Signature Maps at the Protein Level from Digitized Immunohistochemistry Slides

Best Clinical Poster – Bryan Dangott, University of Utah Medical Center; Automated Image Analysis, Scoring & Annotation

Honorable Mention Clinical – Maria Coats, University of Dundee; Optical Projection Tomography as a Diagnostic Tool for Colorectal Polyps

Peoples’ Choice Best Poster – Mohamed Salama, University of Utah; Plasma Cell Spatial Distribution Pattern Correlate with Unique Molecular Profiling Signature

Other big winners at the Pathology Visions Conference were the Travel Award recipients who were chosen based on their understanding of the impact of digital pathology and whole slide imaging in the specialty of pathology. Click here to read more about our winners: Ghassan Allo, MD; Fernando Antelo, MD; Ronald “George” Hauser III, MD; Dianne Kovacic; and Steven Smith, MD, PhD.

If you were able to attend Pathology Visions earlier this month, we want your feedback. Fill out this online evaluation form about the topics and caliber of presenters so we incorporate your feedback into the 2012 Pathology Visions Conference.

Please stay involved with the Digital Pathology Association by joining the discussion on LinkedinFacebook, andTwitter. To join the DPA, please visit our website. If you are already a member and are interested in joining the program, membership, website, regulatory, or white paper committees, please email us at info(at)digitalpathologyassociation(dot)org.

The mission of the Digital Pathology Association is to facilitate education and awareness of digital pathology applications in healthcare and life sciences. Members will be encouraged to share best practices and promote the use of the technology among colleagues in order to demonstrate efficiencies, awareness, and its ultimate benefits to patient care.

 

Source:
http://feeds.feedburner.com/DigitalPathologyBlog

Ventana Medical Systems, Inc. appoints new Medical Director for Digital Pathology

Fernandez to complement the Ventana growing leadership team focused on advancing the standard of cancer patient care

Tucson, 21 November 2011. -- Ventana Medical Systems, Inc.(Ventana), a member of the Roche Group, announced today the appointment of Gerardo (Jerry) Fernandez, M.D., to the position of Medical Director, Ventana Digital Pathology, based in Sunnyvale, CA. Fernandez was most recently Vice President, Pathology of Aureon Biosciences where he also served as VP, Research & Development. Prior to this, Fernandez was an attending Pathologist at Genzyme Genetics and at several hospitals including St. Lukes-Roosevelt Hospital Center and Beth Israel Medical Center.

"Jerry brings considerable experience in quantitative digital imaging and is an outstanding complement to our growing leadership team," said Mara G. Aspinall, President of Ventana. Aspinall herself joined Roche in September, 2011. She was most recently Founder, President, and CEO of On-Q-ity, a start-up diagnostics company focused on circulating tumor cell technology and formerly President of Genzyme Genetics and President of Genzyme Pharmaceuticals. "In line with our mission to improve the lives of all patients afflicted with cancer, Jerry will be working closely across Ventana and Roche organizations with a focus on enabling our customers to deliver the highest standards of patient care through the most advanced digital pathology technologies and solutions available.”

Steve Burnell, VP, Ventana Digital Pathology, commented, "Digital pathology is transforming the practice of pathology in ways that will significantly impact healthcare delivery globally. Innovation in digital technologies is empowering pathologists and clinicians worldwide with tools for more efficient, repeatable, and accurate diagnoses and increasing patient access to skilled pathologists and sub-specialties. VENTANA next-generation, digital pathology solutions fully leverage our unique strengths in high quality staining platforms, assays, and innovative workflow solutions to deliver a complete end-to-end solution for pathology. In his new role, Jerry will help further shape and accelerate our digital pathology vision and commitment to personalized healthcare as a key interface and resource to the Ventana and Roche product development teams and the external medical and scientific communities.” VENTANA advanced workflow and digital pathology products include the VANTAGE workflow solution, the iScan Coreo Au slide scanner and VIRTUOSO software for image management functionality from acquisition through reporting. The VENTANA iScan HT slide scanner, launching soon, will also be integrated with VIRTUOSO.

Fernandez holds a Doctorate of Medicine from Drexel University, Philadelphia, PA and a bachelor’s degree in natural science and mathematics from Bennington College, Bennington, VT. He begins his new role in November, 2011.

The VENTANA iScan HT is for research use only. Not for use in diagnostic procedures. Ventana products are for in vitro diagnostic use for specific applications and are research use only for other applications.

About Ventana Medical Systems, Inc.
Ventana Medical Systems, Inc. (“VMSI”) (SIX: RO, ROG; OTCQX: RHHBY), a member of the Roche Group, innovates and manufactures instruments and reagents that automate tissue processing and slide staining for cancer diagnostics. VENTANA solutions are used in clinical histology and drug development research laboratories worldwide. The company’s “Smart Systems” – intuitive, integrated staining and workflow management platforms that optimize laboratory efficiencies to reduce errors – support diagnosis and inform treatment decisions for anatomic pathology professionals. Together with Roche, VMSI is driving personalized medicine through accelerated drug discovery and the development of “companion diagnostics” to identify the patients most likely to respond favorably to specific therapies. Visit http://www.ventana.com to learn more.

VENTANA, the VENTANA logo, VANTAGE, iScan, and VIRTUOSO are trademarks of Roche.

 http://www.ventana.com

 

Source:
http://feeds.feedburner.com/DigitalPathologyBlog

Grand Guignol Spectacular: Tickets Now Available, Fundrasing Drive, and Film of Final Performance!

Above is a narrated scene from the final performance--circa 1962--of the Grand Guignol, a Parisian theatre infamous from its opening in 1897 until it final performance in 1962 for naturalistic theatrical productions merging horror and elegance, sex and death, fear and humor.

To celebrate my 40th birthday this year, my friend John Del Gaudio and I are putting together a Grand Guignol-inspired variety show that will take place at The Coney Island Museum in Brooklyn this December 10th at 8:00 PM. Tickets are $25 and include not only a night of horror variety theatre, but also a masquerade after party and complementary Hendricks Gin Cocktails prepared by Friese Undine.

The evening was developed in conversation with UC Berkeley's Mel Gordon, author of Grand Guiginol: Theatre of Fear and Terror and will feature a newly commissioned set by NYU’s Chris Muller, stagings of classic Grand Guignol plays, a toy theater version of Bryusov’s “The Sisters,” short films, song and dance, WWI 3D glass plate projection with theremin accompaniment, and more.

We are in the process of trying to raise funds with which to pay all participators a modest stipend and expenses. If you are interested in contributing to this campaign--and/or in finding out more about the evening, including the full lineup thus far--click here. Donations of $100 or more earn contributers a free ticket to the festivities, while donations of lesser amounts earn you a listing in the program; donations of any amount will earn our deepest and heartfelt gratitude!

Whether you are able to contribute or not, I would love to see you at the event! Tickets for the event have just gone on sale, so if you are interested in attending, please click here to purchase.

Thanks so much, and hope to ring in a new decade with you at Coney Island!

Source:
http://morbidanatomy.blogspot.com/feeds/posts/default?alt=rss

William Cheselden Giving an Anatomical Demonstration to Six Spectators in the Anatomy-theatre of the Barber-Surgeons' Company, London, Circa 1730/1740

In Cheselden’s time, surgeons trained through an apprenticeship during which, they would attend private anatomy lessons. Before the Anatomy Act of 1832, the only legal supply of bodies for anatomical purposes where those of criminals condemned by the courts. The Barber-Surgeons’ Company kept scrupulous control over the use of bodies dissected in their hall, with the macabre ritual of often later displaying the dissected bodies of executed criminals in niches around the walls. Cheselden himself was fined by the Company in 1714 for carrying out dissections without permission, which drew away audience members from regular lectures at the Company. With students having little opportunity to take part in dissections themselves, teachers would rely on models or anatomical preparations for class...

Image and text from The Wellcome Collection blog; you can learn more about this fabulous painting--and read the text in its entirety--by clicking here.

Full image credit: William Cheselden giving an anatomical demonstration to six spectators in the anatomy-theatre of the Barber-Surgeons' Company, London. Oil painting, ca. 1730/1740. Wellcome Images.

Source:
http://morbidanatomy.blogspot.com/feeds/posts/default?alt=rss

Arnie Gundersen

Helen's sites: ifyoulovethisplanet.org http://www.helencaldicott.com Arnie's site: fairewinds.com All info below from: ifyoulovethisplanet.org Arnold Gundersen with the latest on the Fukushima meltdowns; a clip of Dr. Caldicott's speech at the Berlin Chernobyl conference - June 17th, 2011 This week, Dr. Caldicott has an in-depth conversation with Arnold Gundersen, energy advisor with Fairewinds Associates Inc.

See the original post:
Arnie Gundersen